Tirzepatide and heart : r/PeterAttia
US$ 24.60
glp-1 obesity drug market news today Receptor Agonists Drugs Size, Trends, Growth Report 2032 How Supply and Demand for
Description
Next, we studied 380,438 patients without diabetes who were prescribed a GLP-1 or other weight loss medication and who had a visit between January 1, 2017, and October 31, 2024
GLP-1 RAs have become more common among a younger and female population, with women constituting 47% of incident patients in 2019 compared to 53% in 2023
In a single-arm retrospective analysis by Firkins et al., clinical outcomes in GLP-1 RA users undergoing EGD were assessed [29]
A benchmark, expand, and calibration (BenchExCal) trial emulation approach for using real-world evidence to support indication expansions: design and process for a planned empirical evaluation
PMC 12739101